Outcomes of patients with active cancer after transcatheter aortic valve replacement: an updated meta-analysis
Patients with active cancer undergoing TAVR had higher non-cardiovascular mortality and bleeding rates, with comparable incidences of other complications. This highlights the need for a shared decision and appropriate patient selection considering cancer type, staging, bleeding risk, and optimal timing for intervention.
Authors
- Allêh Nogueira (ORCID: https://orcid.org/0000-0001-5995-6179)
- Pedro E P Carvalho (ORCID: https://orcid.org/0000-0002-0918-6759)
- Thomaz Alexandre Costa (ORCID: https://orcid.org/0000-0003-1789-6694)
- Lucas Tramujas (ORCID: https://orcid.org/0000-0002-6003-1314)
- Nicole Felix (ORCID: https://orcid.org/0000-0001-8174-3866)
- Philippe Garot (ORCID: https://orcid.org/0009-0001-8960-7006)
- Stephanie Feldman (ORCID: https://orcid.org/0000-0001-6045-2365)
- Giuliano Generoso (ORCID: https://orcid.org/0000-0002-1010-2428)
- Maria do Carmo Andrade Duarte de Farias (ORCID: https://orcid.org/0000-0002-4340-8300)
Institutions
- Escola Bahiana de Medicina e Saúde Pública (BR)
- Cornell University (US)
- Universidade Federal de Campina Grande (BR)
- Minneapolis Heart Institute Foundation (US)
- Institut Cardiovasculaire Paris Sud (FR)
- Hospital Sírio-Libanês (BR)
- Hôpital Privé Jacques Cartier (FR)
- University of Colorado Denver (US)
Publication Details
- Journal
- Cardio-Oncology
- Published
- 2024-09-02
- DOI
- https://doi.org/10.1186/s40959-024-00256-8
- Citations
- 3
- Primary Topic
- Cardiac Valve Diseases and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 1.21